Norepinephrine storage vesicle release mechanism

The norepinephrine storage vesicle release mechanism refers to the regulated process by which norepinephrine, a monoamine neurotransmitter, is released from neuronal synaptic vesicles into the synaptic cleft in response to an action potential. After synthesis within the neuron, norepinephrine is stored in vesicles via the vesicular monoamine transporter (VMAT)[1][3]. Upon neuronal depolarization, voltage-gated calcium channels open, allowing calcium influx. Calcium activates molecular machinery—primarily the SNARE protein complex (including synaptobrevin, syntaxin, SNAP-25) and synaptotagmin—which orchestrates vesicle fusion with the neuronal membrane and subsequent exocytosis of norepinephrine into the synaptic cleft[2][8]. Once released, norepinephrine acts on adrenergic receptors of postsynaptic cells and is cleared primarily by reuptake through the norepinephrine transporter (NET)[7]. Drugs such as reserpine and amphetamines can modulate this process. Dysregulation of vesicular release is implicated in diseases affecting noradrenergic signaling, including cardiovascular and neurodegenerative disorders[3][6]. This query is best understood as referencing a molecular mechanism, not a specific receptor, transporter, or enzyme, and thus cannot be mapped directly to a canonical drug target.

Other names

Neurotransmitter vesicle exocytosisNeurotransmitter release mechanismMonoamine vesicle releaseSynaptic vesicle exocytosis

VMAT (vesicular monoamine transporter) inhibition (e.g., by reserpine)[1][3]; Enhancement of calcium-dependent exocytosis (e.g., by amphetamines[2]); SNARE complex interference; α2-adrenergic receptor modulation (inhibits vesicular release via negative feedback)[6]